AION Labs incubating subsequent drug construction step forward | Israel Times

spsingh
1 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

This week, Israel Times’s Yuval Levy and Abigail Rubinstein interview AION Labs CTO Dr. Yair Benita.

Yuval, Abigail, and Yair will speak about fresh developments within the AI pharmaceutical business, in addition to the paintings AION Labs is doing to propel technological innovation within the box of drug construction.

Yair will talk about his project studio’s collaboration with primary companies akin to Pfizer, Merck, Teva, AstraZeneca, and Amazon to give a boost to impartial Israeli startups as they pursue answers to probably the most greatest demanding situations within the clinical box.

He’ll additionally dive into the main points of AI within the medical global and what the longer term holds for the sector of drugs. Your go-to podcast for all issues to do with innovation in Israel.

Sign up for Eve Younger as she delves into the center of Israel’s tech and industry scenes and uncovers the groundbreaking concepts and visionary minds operating to form the longer term. Sign up for her every week as she shines a focus on the newest tendencies and entrepreneurial spirit, propelling Israel to the leading edge of world innovation.

Pay attention right here, on Apple, Spotify, or anywhere you get your podcasts.

Website |  + posts
author avatar
spsingh
Share This Article